Suprax Returning To Market
This article was originally published in The Pink Sheet Daily
The cephalosporin antibiotic Suprax (cefixime) is returning to the market after a one-year absence
You may also be interested in...
Ventiv Health will provide Lupin Pharmaceuticals with 45 specialized sales representatives for the re-launch of the antibiotic Suprax (cefixime)
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.